Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

The increasing incidence of anticoagulant-associated intracerebral hemorrhage.

Flaherty ML, Kissela B, Woo D, Kleindorfer D, Alwell K, Sekar P, Moomaw CJ, Haverbusch M, Broderick JP.

Neurology. 2007 Jan 9;68(2):116-21.

PMID:
17210891
2.

Location and outcome of anticoagulant-associated intracerebral hemorrhage.

Flaherty ML, Haverbusch M, Sekar P, Kissela BM, Kleindorfer D, Moomaw CJ, Broderick JP, Woo D.

Neurocrit Care. 2006;5(3):197-201.

PMID:
17290088
3.

Anticoagulant-associated intracerebral hemorrhage.

Flaherty ML.

Semin Neurol. 2010 Nov;30(5):565-72. doi: 10.1055/s-0030-1268866. Epub 2011 Jan 4. Review.

PMID:
21207349
4.

Warfarin-associated intracerebral hemorrhage after ischemic stroke.

Åsberg S, Eriksson M, Henriksson KM, Terént A.

Stroke. 2014 Jul;45(7):2118-20. doi: 10.1161/STROKEAHA.114.005729. Epub 2014 May 15.

5.

Incidence of first-ever ischemic and hemorrhagic stroke in a well-defined community of southern Italy, 1993-1995.

Intiso D, Stampatore P, Zarrelli MM, Guerra GL, Arpaia G, Simone P, Tonali P, Beghi E.

Eur J Neurol. 2003 Sep;10(5):559-65.

PMID:
12940839
6.

Antithrombotic drug uses and deep intracerebral hemorrhages in stroke patients with deep cerebral microbleeds.

Imaizumi T, Inamura S, Kohama I, Yoshifuji K, Nomura T, Komatsu K.

J Stroke Cerebrovasc Dis. 2013 Aug;22(6):869-75. doi: 10.1016/j.jstrokecerebrovasdis.2012.08.003. Epub 2012 Sep 6.

PMID:
22959109
7.

Warfarin-associated intracerebral hemorrhage is increasing in prevalence in the United States.

Liotta EM, Prabhakaran S.

J Stroke Cerebrovasc Dis. 2013 Oct;22(7):1151-5. doi: 10.1016/j.jstrokecerebrovasdis.2012.11.015. Epub 2013 Jan 1.

PMID:
23287421
8.

Temporal Trends in Sex Differences With Regard to Stroke Incidence: The Dijon Stroke Registry (1987-2012).

Giroud M, Delpont B, Daubail B, Blanc C, Durier J, Giroud M, Béjot Y.

Stroke. 2017 Apr;48(4):846-849. doi: 10.1161/STROKEAHA.116.015913. Epub 2017 Mar 8.

PMID:
28275198
9.

Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.

Kono S, Deguchi K, Morimoto N, Kurata T, Deguchi S, Yamashita T, Ikeda Y, Matsuura T, Narai H, Omori N, Manabe Y, Yunoki T, Takao Y, Kawata S, Kashihara K, Abe K.

J Stroke Cerebrovasc Dis. 2013 Apr;22(3):190-6. doi: 10.1016/j.jstrokecerebrovasdis.2011.07.016. Epub 2011 Oct 2.

PMID:
21968092
10.

Leukoaraiosis is associated with warfarin-related hemorrhage following ischemic stroke.

Smith EE, Rosand J, Knudsen KA, Hylek EM, Greenberg SM.

Neurology. 2002 Jul 23;59(2):193-7.

PMID:
12136056
11.

Racial variations in location and risk of intracerebral hemorrhage.

Flaherty ML, Woo D, Haverbusch M, Sekar P, Khoury J, Sauerbeck L, Moomaw CJ, Schneider A, Kissela B, Kleindorfer D, Broderick JP.

Stroke. 2005 May;36(5):934-7. Epub 2005 Mar 24.

12.

Effect of warfarin on intracranial hemorrhage incidence and fatal outcomes.

Witt DM, Delate T, Hylek EM, Clark NP, Crowther MA, Dentali F, Ageno W, Martinez KD, Garcia DA.

Thromb Res. 2013;132(6):770-5. doi: 10.1016/j.thromres.2013.10.024. Epub 2013 Oct 17.

PMID:
24521790
13.

The unchanging incidence and case-fatality of stroke in the 1990s: a population-based study.

Kleindorfer D, Broderick J, Khoury J, Flaherty M, Woo D, Alwell K, Moomaw CJ, Schneider A, Miller R, Shukla R, Kissela B.

Stroke. 2006 Oct;37(10):2473-8. Epub 2006 Aug 31.

14.

Sex-specific stroke incidence over time in the Greater Cincinnati/Northern Kentucky Stroke Study.

Madsen TE, Khoury J, Alwell K, Moomaw CJ, Rademacher E, Flaherty ML, Woo D, Mackey J, De Los Rios La Rosa F, Martini S, Ferioli S, Adeoye O, Khatri P, Broderick JP, Kissela BM, Kleindorfer D.

Neurology. 2017 Sep 5;89(10):990-996. doi: 10.1212/WNL.0000000000004325. Epub 2017 Aug 9.

PMID:
28794254
15.

The Greater Cincinnati/Northern Kentucky Stroke Study: preliminary first-ever and total incidence rates of stroke among blacks.

Broderick J, Brott T, Kothari R, Miller R, Khoury J, Pancioli A, Gebel J, Mills D, Minneci L, Shukla R.

Stroke. 1998 Feb;29(2):415-21.

16.

Incidence and trends of stroke and its subtypes in China: results from three large cities.

Jiang B, Wang WZ, Chen H, Hong Z, Yang QD, Wu SP, Du XL, Bao QJ.

Stroke. 2006 Jan;37(1):63-8. Epub 2005 Nov 23.

17.

Risk of stroke associated with nonsteroidal anti-inflammatory drugs: a nested case-control study.

Bak S, Andersen M, Tsiropoulos I, García Rodríguez LA, Hallas J, Christensen K, Gaist D.

Stroke. 2003 Feb;34(2):379-86.

18.

A population-based prospective 24-month study of stroke: incidence and 30-day case-fatality rates of first-ever strokes in Croatia.

Pikija S, Cvetko D, Malojčić B, Trkanjec Z, Pavliček I, Lukić A, Kopjar A, Hajduk M, Andrović A, Bilić-Genter M, Trkulja V.

Neuroepidemiology. 2012;38(3):164-71. doi: 10.1159/000336114. Epub 2012 Mar 29.

PMID:
22473420
19.

Stroke incidence and usage rate of thrombolysis in a Japanese urban city: the Kurashiki stroke registry.

Iguchi Y, Kimura K, Sone K, Miura H, Endo H, Yamagata S, Koide H, Suzuki K, Kimura T, Sakurai M, Mishima N, Yoshii K, Fujisawa H, Ebisutani S; Kurashiki Stroke Registry investigators.

J Stroke Cerebrovasc Dis. 2013 May;22(4):349-57. doi: 10.1016/j.jstrokecerebrovasdis.2011.09.015. Epub 2011 Nov 2.

PMID:
22051352
20.

Epidemiology of stroke and its subtypes in Chinese vs white populations: a systematic review.

Tsai CF, Thomas B, Sudlow CL.

Neurology. 2013 Jul 16;81(3):264-72. doi: 10.1212/WNL.0b013e31829bfde3. Review.

Supplemental Content

Support Center